162 related articles for article (PubMed ID: 34629464)
1. A PCR-amplified transgene fragment flanked by a single copy of a truncated inverted terminal repeat for recombinant adeno-associated virus production prevents unnecessary plasmid DNA packaging.
Adachi K; Tomono T; Okada H; Shiozawa Y; Yamamoto M; Miyagawa Y; Okada T
Gene Ther; 2022 Aug; 29(7-8):449-457. PubMed ID: 34629464
[TBL] [Abstract][Full Text] [Related]
2. Impact of Inverted Terminal Repeat Integrity on rAAV8 Production Using the Baculovirus/Sf9 Cells System.
Savy A; Dickx Y; Nauwynck L; Bonnin D; Merten OW; Galibert L
Hum Gene Ther Methods; 2017 Oct; 28(5):277-289. PubMed ID: 28967288
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the B-B' and C-C' regions of inverted terminal repeats reduces rAAV productivity but increases transgene expression.
Zhou Q; Tian W; Liu C; Lian Z; Dong X; Wu X
Sci Rep; 2017 Jul; 7(1):5432. PubMed ID: 28710345
[TBL] [Abstract][Full Text] [Related]
4. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.
Aurnhammer C; Haase M; Muether N; Hausl M; Rauschhuber C; Huber I; Nitschko H; Busch U; Sing A; Ehrhardt A; Baiker A
Hum Gene Ther Methods; 2012 Feb; 23(1):18-28. PubMed ID: 22428977
[TBL] [Abstract][Full Text] [Related]
5. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
6. Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors.
Zhang J; Chrzanowski M; Frabutt DA; Lam AK; Mulcrone PL; Li L; Konkle BA; Miao CH; Xiao W
J Med Virol; 2023 Jan; 95(1):e28433. PubMed ID: 36571262
[TBL] [Abstract][Full Text] [Related]
7. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.
Wang XS; Ponnazhagan S; Srivastava A
J Virol; 1996 Mar; 70(3):1668-77. PubMed ID: 8627687
[TBL] [Abstract][Full Text] [Related]
8. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
[TBL] [Abstract][Full Text] [Related]
9. [Novel qPCR strategy for quantification of recombinant adeno-associated virus serotype 2 vector genome-titer].
Meng Q; Zhang B; Zhang C
Sheng Wu Gong Cheng Xue Bao; 2013 Feb; 29(2):235-42. PubMed ID: 23697168
[TBL] [Abstract][Full Text] [Related]
10. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
Smith RH; Afione SA; Kotin RM
Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
12. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
13. Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.
Chikhlikar P; Barros de Arruda L; Agrawal S; Byrne B; Guggino W; August JT; Marques ET
Virology; 2004 Jun; 323(2):220-32. PubMed ID: 15193918
[TBL] [Abstract][Full Text] [Related]
14. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
15. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
Wu J; Zhao W; Zhong L; Han Z; Li B; Ma W; Weigel-Kelley KA; Warrington KH; Srivastava A
Hum Gene Ther; 2007 Feb; 18(2):171-82. PubMed ID: 17328683
[TBL] [Abstract][Full Text] [Related]
16. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
17. Construction and gene expression analysis of a single-stranded DNA minivector based on an inverted terminal repeat of adeno-associated virus.
Ping H; Liu X; Zhu D; Li T; Zhang C
Mol Biotechnol; 2015 Apr; 57(4):382-90. PubMed ID: 25555376
[TBL] [Abstract][Full Text] [Related]
18. A capillary electrophoresis sequencing method for the identification of mutations in the inverted terminal repeats of adeno-associated virus.
Mroske C; Rivera H; Ul-Hasan T; Chatterjee S; Wong KK
Hum Gene Ther Methods; 2012 Apr; 23(2):128-36. PubMed ID: 22612656
[TBL] [Abstract][Full Text] [Related]
19. A Novel Next-Generation Sequencing and Analysis Platform to Assess the Identity of Recombinant Adeno-Associated Viral Preparations from Viral DNA Extracts.
Guerin K; Rego M; Bourges D; Ersing I; Haery L; Harten DeMaio K; Sanders E; Tasissa M; Kostman M; Tillgren M; Makana Hanley L; Mueller I; Mitsopoulos A; Fan M
Hum Gene Ther; 2020 Jun; 31(11-12):664-678. PubMed ID: 32159396
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.
McCarty DM; Fu H; Monahan PE; Toulson CE; Naik P; Samulski RJ
Gene Ther; 2003 Dec; 10(26):2112-8. PubMed ID: 14625565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
